Dr. Juandy Jo




Dr. Juandy Jo is a lecturer at Department of Biology. He earned his Degree of Medical Doctor from Universitas Gadjah Mada in Yogyakarta, Master of Molecular Biology from University of Queensland in Brisbane, Australia, and Doctor rerum naturalium from Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-Universität Freiburg in Freiburg im Breisgau, Germany.


  • 2010 - Doctor rerum naturalium. Research group of Prof. Dr. med. Robert Thimme, Spemann Graduate School of Biology and Medicine, Albert-Ludwigs-Universitat Freiburg, Freiburg im Breisgau, Germany
  • 2005 - Master of Molecular Biology. University of Queensland, Brisbane, Australia
  • 2003 - Medical Doctor. Gadjah Mada University, Yogyakarta, Indonesia
  • 2019 - Danone Newgen Leadership Training (with Essec Business School)
  • 2019 - NICF-Certified Associate in Project Management
  • 2018 - Eureka-Singapore Monsoon School on Translational Medicine
  • 2016 & 2017 - ISO 9001:2015 Quality Management Systems Training
  • 2015 - ETC Drug Discovery Course
  • 2015 - SCDF Community Emergency Preparedness Programme
  • 2014 - Danone Finance for Non-Finance Training
  • 2013 - Sign – EMBO Workshop on Complex Systems in Immunology
Work Experiences:
  • 2021-now - Executive Director at Mochtar Riady Institute for Nanotechnology, Tangerang, Indonesia
  • 2020-now - Lecturer at Department of Biology, Faculty of Science and Technology, Pelita Harapan University, Tangerang, Indonesia
  • 2019-2020 - Senior Project Leader, Danone Nutricia Research, Singapore
  • 2018-2019 - Medical Affairs Manager (Secondment), Danone Nutricia Indonesia, Jakarta, Indonesia
  • 2017-2018 - Scientific Analytical Team Leader, Danone Nutricia Research, Singapore
  • 2015-2017 - Senior Immunology Scientist, Danone Nutricia Research, Singapore
  • 2013-2015 - Immunology Scientist, Danone Nutricia Research, Singapore
  • 2010-2013 - Research Fellow, Singapore Institute for Clinical Sciences, A*STAR, Singapore
  • 2006-2007 - Lecturer at Faculty of Medicine, Pelita Harapan University, Tangerang, Indonesia
Publication Journals:
  1. Assessment on anti-SARS-CoV-2 receptor-binding domain antibodies among CoronaVac-vaccinated Indonesian adults
    Clinical and Experimental Vaccine Research, 2022
  2. GOUW, J. W., MEULENBROEK, L. A. P., JO, J., Johannes, K. L. M., & Garssen, J. (2019). Formula with specific beta-lactoglobulin peptides (World Intellectual Property Organization Patent No. WO2019212331A1).
    Google Patents (click here)
  3. GOUW, J. W., MEULENBROEK, L. A. P. M., JO, J., Knippels, L. M. J., & Garssen, J. (2019). Formula with a specific beta-lactoglobulin peptide (World Intellectual Property Organization Patent No. WO2019212332A1).
    Google Patents (click here)
  4. Gouw, J. W.*, Jo, J.*, Meulenbroek, L. A. P. M., Heijjer, T. S., Kremer, E., Sandalova, E., Knulst, A. C., Jeurink, P. V., Garssen, J., Rijnierse, A., & Knippels, L. M. J. (2018). Identification of peptides with tolerogenic potential in a hydrolysed whey-based infant formula. Clinical and Experimental Allergy: Journal of the British Society for Allergy and Clinical Immunology, 48(10), 1345-1353. doi: 10.1111/cea.13223
  5. Garssen, J., & Jo, J. (2017). Genetically-engineered T cells to treat viral hepatitis-associated liver cancer: is it possible? AIMS Allergy & Immunology, 1(1), 43-49. doi: 10.3934/Allergy.2017.1.43
  6. Tan-Garcia, A., Lu-En, W., Zheng, D., Ceccarello, E., Jo, J., Banu, N., Khakpoor, A., Chia, A., Tham, C. Y. L., Tan, A. T., Hong, M., Keng, C. T., Rivino, L., Tan, K. C., Lee, K. H., Lim, S. G., Newell, E. W., Pavelka, N., Chen, J., Ginhoux, F., Chen, Q., Bertoletti, A., & Dutertre, C-A. (2017). Intrahepatic CD206+ macrophages contribute to inflammation in advanced viral-related liver disease. Journal of Hepatology, 67(3), 490-500. doi: 10.1016/j.jhep.2017.04.02
  7. Jo, J., Garssen, J., Knippels, L., & Sandalova, E. (2014). Role of cellular immunity in cow’s milk allergy: pathogenesis, tolerance induction and beyond. Mediators of Inflammation, 2014, 1-10. doi: 10.1155/2014/249784
  8. Jo, J., Tan, A. T., Ussher, J. E., Sandalova, E., Tang, X.-Z., Tan-Garcia, A., To, N., Hong, M., Chia, A., Gill, U. S., Kennedy, P. T., Tan, K. C., Lee, K. H., Libero, G. D.,. Gehring, A. J., Willberg, C. B., Klenerman, P., & Bertoletti, A. (2014). Toll-like receptor 8 agonist and bacteria trigger potent activation of innate immune cells in human liver. PLoS Pathogens, 10(6), e1004210. doi: 10.1371/journal.ppat.1004210
  9. Fletcher, N. F., Sutaria, R., Jo, J., Barnes, A., Blahova, M., Meredith, L. W., Cosset, F.-L., Curbishley, S. M., Adams, D. H., Bertoletti, A., & McKeating, J. A. (2014). Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology, 59(4), 1320-1330. doi: 10.1002/hep.26911
  10. Negash, A. A., Ramos, H. J., Crochet, N., Lau, D. T. Y., Doehle, B., Papic, N., Delker, D. A., Jo, J., Bertoletti, A., Hagedorn, C. H., & Gale, M. (2013). IL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and disease. PLoS Pathogens, 9(4), e1003330. doi: 10.1371/journal.ppat.1003330
  11. Tang, X. Z.*, Jo, J.*, Tan, A. T.*, Sandalova, E.*, Chia, A., Tan, K. C., Lee, K. H.,. Gehring, A. J., Libero, G. D., & Bertoletti, A. (2013). IL-7 licenses activation of human liver intrasinusoidal mucosal-associated invariant T cells. The Journal of Immunology, 190(7), 3142-3152. doi: 10.4049/jimmunol.1203218
  12. Kennedy, P., Sandalova, E., Jo, J., Gill, U., Ushiro-Lumb, I., Tan, A. T., Naik, S., Foster, G., & Bertoletti, A. (2012). Preserved T cell function in children and young adults with immune tolerant chronic hepatitis B. Gastroenterology, 143(3), 637-645. doi: 10.1053/j.gastro.2012.06.009
  13. Jo, J., Bengsch, B., Seigel, B., Rau, S. J., Schmidt, J., Bisse, E., Aichele, P., Aichele, U., Joeckel, L., Royer, C., Ferreira, K. S., Borner, C., Baumert, T. F., Blum, H. E., Lohmann, V., Fischer, R., & Thimme, R. (2012). Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential. Journal of Hepatology, 57(1), 9- 16. doi: 10.1016/j.jhep.2012.02.030
  14. Jo, J., Lohmann, V., Bartenschlager, R., & Thimme, R. (2011). Experimental models to study the immunobiology of hepatitis C virus. The Journal of General Virology, 92(3), 477-493. doi: 10.1099/vir.0.027987-0
  15. Jo, J., Aichele, U., Kersting, N., Klein, R., Aichele, P., Bisse, E., Sewell, A. K., Blum, H. E., Bartenschlager, R., Lohmann, V., & Thimme, R. (2009). Analysis of CD8+ Tcell- mediated inhibition of hepatitis C virus replication using a novel immunological model. Gastroenterology, 136(4), 1391-1401. doi: 10.1053/j.gastro.2008.12.034
  16. Jo, J., Tan, A. T., & Bertoletti, A. (2013). Murine models and human studies of pathogenesis of chronic hepatitis B. In Howard C. Thomas, Anna S. F. Lok, Stephen A. Locarnini & Arie J. Zuckerman (Eds.) Viral Hepatitis, 4th edition (pp. 176-187). New Jersey: Wiley-Blackwell.
view Google Scholar (click here)